TILMIX INJECTION

Země: Austrálie

Jazyk: angličtina

Zdroj: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Aktivní složka:

TILMICOSIN PHOSPHATE

Dostupné s:

Jurox Pty Limited

INN (Mezinárodní Name):

tilmicosin(300mg/mL)

Léková forma:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Složení:

TILMICOSIN PHOSPHATE ANTIBIOTIC Active 300.0 mg/ml

Jednotky v balení:

100mL; 250mL

Třída:

VM - Veterinary Medicine

Terapeutické skupiny:

CATTLE - FEEDLOT | BEEF | BOVINE | DAIRY COW

Terapeutické oblasti:

ANTIBIOTIC & RELATED

Terapeutické indikace:

BOVINE RESPIRATORY DISEASE | SHIPPING FEVER

Přehled produktů:

Poison schedule: 4; Withholding period: WITHOLDING PERIODS: MEAT- Do not use l ess than 35 days before slaughter for h uman comsumption. MILK: Do not use in c ows that are producing or may in the fu ture produce milk or milk products for human comsumption. TRADE ADVICE EXPOR T SLAUGHTER INTERVAL (ESI): Do not use less than 91 days before slaughter for export. The ESI on this label was corre ct at the time of label approval. Befor e using this product confirm the curre nt ESI from Jurox Pty Ltd on 1800 023 3 12 or the APVMA website (www.apvma.gov .au/residues/ESI.shtml).; Host/pest details: CATTLE - FEEDLOT: [BOVINE RESPIRATORY DISEASE]; Poison schedule: 4; Withholding period: ; Host/pest details: CATTLE - FEEDLOT: [BOVINE RESPIRATORY DISEASE]; For use in lot-fed cattle for the treatment of Bovine Respiratory Disease (BRD) associated with Mannheimia (Pasteurella) haemolytica, Pasteurella multocida, and other organisms susceptible to tilmicosin.NOT to be administered intravenously or intramuscularly. Inject subcutaneously only in cattle. For RESTRAINTS, see product label. NOT for use in pigs. Do not use pneumatic or hydraulic syringes.

Stav Autorizace:

Stopped

Datum autorizace:

2020-07-01

Informace pro uživatele

Overall size 230mm x 242.5mm
is 100% size
230mm
242.5mm
8
9
0
1
2
7
6
5
4
3
12
TILMIX
®
INJECTION
100ML
TILMIX
®
PRESCRIPTION
ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
INJECTION
ACTIVE CONSTITUENT:
300 MG/ML TILMICOSIN
(as Tilmicosin Phosphate)
For use in lot-fed cattle for the treatment
of Bovine Respiratory Disease (BRD)
associated with _Mannheimia_
_(Pasteurella) haemolytica_,_ Pasteurella_
_multocida_, and other organisms
susceptible to tilmicosin.
FOR SUBCUTANEOUS INJECTION
ONLY IN CATTLE
100ML
TILMIX
®
PRESCRIPTION
ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
INJECTION
ACTIVE CONSTITUENT:
300 MG/ML TILMICOSIN
(as Tilmicosin Phosphate)
For use in lot-fed cattle for the treatment
of Bovine Respiratory Disease (BRD)
associated with _Mannheimia_
_(Pasteurella) haemolytica_,_ Pasteurella_
_multocida_, and other organisms
susceptible to tilmicosin.
FOR SUBCUTANEOUS INJECTION
ONLY IN CATTLE
100ML
APVMA FILE: 63564 _45957_100mL_PRIMARY_MPL_V02.PDF
Dimensions: primary pack = 230mm (wide) x 242.5 (high)
Scale: 100% of A3
Date: 19 - 11 - 2009
B
EXP
NOTE TO DOCTOR: The cardiovascular system is the
target of toxicity and should be monitored closely.
This antibiotic persists in tissues for several days.
Apply ice to injection site and provide supportive
treatment. Dobutamine partially offset the negative
inotropic effects induced by tilmicosin in dogs.
Epinephrine potentiated the lethality of tilmicosin
in
pigs.
β-adrenergic
antagonists,
such
as
propranolol, exacerbated the negative inotropy of
tilmicosin-induced tachycardia in dogs.
Made in Australia by:
Jurox Pty Ltd
85 Gardiner Rd,
Rutherford NSW 2320
Infoline 1800 023 312
DISPOSAL:
Dispose
of
empty
container
by
wrapping
with
paper
and
putting
in
garbage.
Discarded needles should immediately be placed
in a designated and appropriately labelled “sharps”
container.
Storage: Store below 30°C (Room Temperature).
Protect from direct sunlight. Use the contents of the
vial within 90 days of initial broaching and d

Charakteristika produktu

TILMIX Injection
Page 1 of 5
ISSUED:
26 MAY 2015
MATERIAL SAFETY DATA SHEET
SECTION 1: IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
PRODUCT NAME:
TILMIX INJECTION
PRODUCT CODE:
503730 (100 mL); 503735 (250 mL)
RECOMMENDED USE:
For use in lot-fed cattle for the treatment of Bovine Respiratory
Disease
(BRD) associated with _Mannheimia (Pasteurella) haemolytica,
Pasteurella _
_multocida_, and other organisms susceptible to tilmicosin.
COMPANY IDENTIFICATION:
Jurox Pty Limited
ADDRESS:
85 Gardiner Road
Rutherford NSW 2320
Australia
CUSTOMER CENTRE:
1800 023 312
NATIONAL POISONS INFORMATION CENTRE:
131126 (Australia-wide)
EMERGENCY TELEPHONE NUMBER:
1800 023 312
SECTION 2: HAZARDS IDENTIFICATION
HAZARD CLASSIFICATIONS:
CONSIDERED A HAZARDOUS SUBSTANCE ACCORDING TO THE CRITERIA OF NOHSC
AUSTRALIA.
NOT CONSIDERED A DANGEROUS GOOD ACCORDING TO THE CRITERIA OF THE
AUSTRALIAN
DANGEROUS GOODS (ADG) CODE.
POISONS SCHEDULE:
S4
CAUTION STATEMENT:
INJECTION OF TILMICOSIN PHOSPHATE HAS BEEN ASSOCIATED WITH HUMAN
FATALITIES
RISK PHRASES:
Harmful by inhalation, if swallowed or injected
Irritating to eyes
May cause SENSITISATION by inhalation ad skin contact
Cumulative effects may result following exposure
Very toxic to aquatic organisms
May cause long-term adverse effects in the aquatic environment
SAFETY PHRASES:
Keep out of reach of children
Read label before use
Exercise extreme caution to avoid accidental self-injection
Avoid contact with skin
Avoid contact with eyes
Do not breathe vapours
Wear suitable protective clothing (including eye/face protection)
Use only in well-ventilated areas
Keep container in a well-ventilated place
Use water to clean the floor and all objects contaminated by this
material
Keep container tightly closed
Keep away from food, drink and animal feeding stuffs
If exposed, IMMEDIATELY contact a Doctor or Poisons Information Centre
(show this
container or label)
TILMIX Injection
Page 2 of 5
SECTION 3: COMPOSITION / INFORMATION ON INGREDIENTS
INGREDIENT
CAS NO.
CONTENT
Tilmicosin phosphate
137330-13-3
30